Abbott Laboratories (ABT) Stock Price

$130.8 0.4%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    5

  • Fundamental

    9

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Abbott Laboratories, AI stock picks, stock alerts and much more.

Sign up

ABT AI Stock Analysis

AI stock analysis for ABT is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Abbott Laboratories (ABT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Abbott Laboratories (ABT) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Abbott Laboratories (ABT), currently trading at $130.8, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ABT

LSE

  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.

  • Symbol

    ABT

  • Market

    NYSE

  • Industry

    Medical - Devices

  • Market Cap

    226.9B

Similar Stocks

BSX Boston Scientific
BSX		 $99.36
1.4%
6
EW Edwards Lifesciences
EW		 $70.91
0.4%
4
MDT Medtronic
MDT		 $87.63
1.5%
6
SYK Stryker
SYK		 $364.5
0.8%
6
AVNS Avanos Medical
AVNS		 $13.95
2.7%
5

News

Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday

Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday
March 27, 2025. fool.com
Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
March 27, 2025. prnewswire.com
Abbott Hosts Conference Call for First-Quarter Earnings

Abbott Hosts Conference Call for First-Quarter Earnings
March 26, 2025. prnewswire.com
ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System

ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System
March 25, 2025. zacks.com

ABT Alternative Data

Web Traffic

Abbott Laboratories receives an estimated 964142 monthly visitors to abbott.com.

  • Web Traffic

    964142

  • Change from Previous Month

    3.7%

  • 3 Month Change

    12%

  • YoY Change

    12%

News Mentions

Abbott Laboratories was mentioned 8 times in the news yesterday.

  • News Mentions

    8

  • Daily Change

    100%

  • 1 Month Change

    300%

  • 3 Month Change

    60%

Reddit Mentions

Abbott Laboratories has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

Twitter Followers

Abbott Laboratories has 124,392 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.

  • Twitter Followers

    124392

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.2%

  • YoY Change

    0.2%

Facebook Engagement

Abbott Laboratories has engaged 601 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    601

  • Daily Change

    3.8%

  • 1 Month Change

    80.2%

  • 3 Month Change

    97.3%

  • YoY Change

    97.3%

LinkedIn Followers

3,839,415 are following Abbott Laboratories on LinkedIn, up by 0.2% over the last month.

  • LinkedIn Followers

    3839415

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    1.4%

Job Postings

Abbott Laboratories currenly has an estimated 2,000 open job postings.

  • Job Postings

    2000

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Instagram Followers

Abbott Laboratories has 258,724 Instagram Followers on its main Instagram account, up by 1.3% over the last month.

  • Instagram Followers

    258724

  • Daily Change

    0.1%

  • 1 Month Change

    1.3%

  • 3 Month Change

    4.5%

  • YoY Change

    4.5%

LinkedIn Employees

According to LinkedIn, Abbott Laboratories has 159,056 employees, down by -1.2% over the last month.

  • LinkedIn Employees

    159056

  • Daily Change

    0.1%

  • 1 Month Change

    1.2%

  • 3 Month Change

    3.1%

  • YoY Change

    3.1%

Business Outlook

According to employee reviews, the business outlook among employees at Abbott Laboratories is 67 out of 100 (bullish).

  • Business Outlook

    67

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

ABT Financials

ABT Key Metrics

  • Total Revenue

    $11B

  • Net Income

    $9.2B

  • Earnings per Share

    $5.33

  • Free cash flow

    $2.1B

  • EBITDA

    $3B

  • EBITDA Ratio

    0.272371

  • Total Assets

    $81.4B

ABT 2-year Revenue & Income
ABT 2-year Free Cash Flow

ABT Technicals

ABT SMA
ABT RSI

FAQ

What's the current price of Abbott Laboratories (ABT) Stock?
The price of an Abbott Laboratories (ABT) share is $130.8.

What's the market cap of Abbott Laboratories?
The current market cap of Abbott Laboratories is 226.9B.

Should I buy or sell ABT?
Abbott Laboratories shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Abbott Laboratories is better viewed as a hold or accumulate position while waiting for further developments.

Is Abbott Laboratories a good investment?
The current analysis of Abbott Laboratories' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Abbott Laboratories' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Abbott Laboratories (ABT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Abbott Laboratories stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Abbott Laboratories (ABT) that investors often compare it to?
Abbott Laboratories (ABT) is often compared to similar stocks such as Boston Scientific, Edwards Lifesciences, Medtronic, Stryker and Avanos Medical.

What is the forecast for Abbott Laboratories' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Abbott Laboratories' stock price to be around $136.5 in 2026. Starting from the current price of $130.8, this represents a 4.3% change in price, indicating a neutral outlook for the stock.

How to buy Abbott Laboratories (ABT) Stock?
Abbott Laboratories stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Abbott Laboratories shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.